Currency in USD
Earnings Estimate | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|
No. of Analysts | 2 | 2 | 2 | 2 |
Avg. Estimate | -0.17 | -0.05 | -0.32 | -0.11 |
Low Estimate | -0.21 | -0.08 | -0.4 | -0.13 |
High Estimate | -0.13 | -0.02 | -0.24 | -0.09 |
Year Ago EPS | -18 | -8.93 | -29.44 | -0.32 |
Revenue Estimate | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|
No. of Analysts | 3 | 3 | 3 | 3 |
Avg. Estimate | 10M | 14.09M | 51.5M | 55.5M |
Low Estimate | 9.7M | 13.79M | 51M | 53.6M |
High Estimate | 10.49M | 14.3M | 52M | 57.21M |
Year Ago Sales | 10.47M | 14.29M | 49.16M | 51.5M |
Sales Growth (year/est) | -4.50% | -1.40% | 4.80% | 7.80% |
Earnings History | 2023-03-30 | 2023-06-29 | 2023-09-29 | 2023-12-30 |
---|
EPS Est. | -19.67 | -5.33 | -1.85 | -2.55 |
EPS Actual | -18 | -8.93 | -3.89 | -1.76 |
Difference | 1.67 | -3.6 | -2.04 | 0.79 |
Surprise % | 8.50% | -67.50% | -110.30% | 31.00% |
EPS Trend | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|
Current Estimate | -0.17 | -0.05 | -0.32 | -0.11 |
7 Days Ago | -0.17 | -0.05 | -0.32 | -0.11 |
30 Days Ago | -0.17 | -0.05 | -0.32 | -0.11 |
60 Days Ago | -0.89 | -0.47 | -1.84 | -0.1 |
90 Days Ago | -1.8 | -1.23 | -4.88 | -1.52 |
EPS Revisions | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|
Up Last 7 Days | N/A | N/A | N/A | N/A |
Up Last 30 Days | N/A | N/A | N/A | N/A |
Down Last 7 Days | N/A | N/A | N/A | N/A |
Down Last 30 Days | N/A | N/A | N/A | N/A |
Growth Estimates | BIOL | Industry | Sector(s) | S&P 500 |
---|
Current Qtr. | 99.10% | N/A | N/A | N/A |
Next Qtr. | 99.40% | N/A | N/A | N/A |
Current Year | 98.90% | N/A | N/A | N/A |
Next Year | 65.60% | N/A | N/A | N/A |
Next 5 Years (per annum) | 20.00% | N/A | N/A | N/A |
Past 5 Years (per annum) | 13.59% | N/A | N/A | N/A |